Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease
- 1 December 1984
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 105 (6) , 991-995
- https://doi.org/10.1016/s0022-3476(84)80097-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in KoreaKorean Circulation Journal, 2019
- Kawasaki Syndrome in the United StatesAmerican Journal of Diseases of Children, 1983
- Clearance ConceptsPublished by Taylor & Francis ,1982
- Efficacy, Disposition and Pharmacodynamics of Aspirin, Acetaminophen and Choline Salicylate in Young Febrile ChildrenTherapeutic Drug Monitoring, 1982
- Kawasaki Syndrome: An UpdateHospital Practice, 1982
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- Salicylate Treatment of Epidemic Kawasaki Disease in New York CityTherapeutic Drug Monitoring, 1979
- Dosage of Salicylates for Children with Juvenile Rheumatoid Arthritis:A Preliminary ReportScandinavian Journal of Rheumatology, 1975
- Rapid determination of salicylate in biological fluidsBiochemical Journal, 1954